Skip to content
FIND A HEALTH VALLEY ACTOR

Swiss biotech companies attracted investments of $3.33 billion in 2021

Biotech

Last year was ‘the second best year in terms of fundraising’, according to the Swiss Biotech Association. The sector benefited from a “still strong” international contribution.   Of the $3.33 billion, $2.51 billion was invested in listed companies, including Sophia Genetics in Lausanne, with $234 million following its initial public offering (IPO) and its follow-up,…

Read More

Swiss Medtech Day

Swiss Medtech Day

The Swiss Medtech Day is taking place on 9 June 2027 in Kursaal, Bern. The overarching theme for 2024-2026 is Mastering Complexity. This theme addresses the dynamic changes in the world and the challenges faced by the medical technology industry. The Swiss Medtech Day provides a platform for discussing these challenges. By sharing experiences, best…

Read More

Podcast: Claude Clément

Claude Clément

BioAlps President, Claude Clément, discusses career choices and how to lead innovation in the healthcare industry in the podcast What To Do Next? Claude Clément first worked in R&D for the watch industry (Swatch Group🇨🇭), then entered the world of medical technologies by heading the diversification activities of Swatch in the field of wearable programmable drug delivery…

Read More

Merck Serono improves quality control with IA

Merck Serono Christophe Martin

Artificial Intelligence helps to assess the severity of a manufacturing incident in a medicine production unit   In any factory, every day, a problem occurs. But when it happens at a site that manufactures cancer or multiple sclerosis drugs, the consequences can turn into a catastrophe. In order to make the right decisions as quickly…

Read More

EUR 1 million Eurostars grant for Limula and Ceidos

Limula Ceidos Stemmatters

The two swiss biotech startups signed an agreement with Stemmatters in Portugal. They received a Eurostars grant of EUR 1.14 million to merge their expertise to develop platforms for the automated production of cell and gene therapy products.   Chimeric antigen receptor (CAR) T-cell therapies have shown exceptional clinical efficacy for the treatment of multiple…

Read More

Switzerland is high on the financing of medical startups

startup invest

Switzerland ranks fourth in Europe in terms of the number of deals behind Britain, Germany and France.   Last year, investments in startups reached CHF 2.78 billion, half the amount in 2020 according to a survey by EY Switzerland Venture capital. In terms of volume, Switzerland is the seventh-largest country in Europe. The number of…

Read More

Plair SA raised CHF 2,7 million

A grant to fund the Rapid-C Real-Time Microbial Detector    Plair SA, based in Plan-les-Ouates, Geneva, has been awarded CHF 2.7 million in funding from the State Secretariat for Education, Research and Innovation SERI and the EIC Accelerator (former SME Instrument), a highly competitive programme of the European Commission offering funding, coaching and business acceleration services…

Read More

Artiria Medical raised CHF 3.8 million to improve stroke treatment

Artiria Medical

Artiria Medical, a swiss neurovascular start-up, raised CHF 3.8 M, including a CHF 2.7 M grant from the highly selective EIC accelerator program and a CHF 1.1 M bridge financing. With its breakthrough technology, Artiria Medical has been awarded the highly selective EIC Accelerator Grant supporting disruptive innovation across Europe, funded by the Swiss State…

Read More

An electronic implant helps a bedridden patient to walk again

Neuro Restore

Researchers at the NeuroRestore research center in Lausanne Switzerland helped a patient suffering from a neurogenerative disease to leave her bed without fainting.   Jocelyne Bloch, neurosurgeon at the CHUV and professor at the UNIL in Lausanne Switzerland, and Grégoire Courtine, professor in neurosciences at the EPFL, and their teams, have enabled a 48-year-old woman…

Read More

Neurosoft Bioelectronics raised CHF 3 Million

Neurosoft Bioelectronics

The Geneva-based company developed soft and flexible electrodes which can seamlessly interface with the brain   Neurosoft Bioelectronics, an early-stage company developing tools for unmet needs in epilepsy and tinnitus, was awarded nearly $3 million, from the SERI-Funded European Innovation Council Accelerator Grant and a share of the $165 000 through the European Research Council…

Read More